These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
482 related items for PubMed ID: 18277196
1. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C. Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196 [Abstract] [Full Text] [Related]
2. Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction. Giallauria F, Lucci R, De Lorenzo A, D'Agostino M, Del Forno D, Vigorito C. Age Ageing; 2006 Nov; 35(6):601-7. PubMed ID: 16951263 [Abstract] [Full Text] [Related]
3. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, Possemiers N, Wuyts FL, Vrints CJ. Eur Heart J; 2004 Oct; 25(20):1797-805. PubMed ID: 15474694 [Abstract] [Full Text] [Related]
4. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E. Cardiol J; 2009 Oct; 16(1):43-9. PubMed ID: 19130415 [Abstract] [Full Text] [Related]
5. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction. Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L. Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185 [Abstract] [Full Text] [Related]
6. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D. Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624 [Abstract] [Full Text] [Related]
7. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Tschöpe C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP. Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646 [Abstract] [Full Text] [Related]
9. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients. Choi SY, Lee JE, Jang EH, Kim MO, Baek H, Ki CS, Park SW, Kim DJ, Huh WS, Oh HY, Kim YG. Nephron Clin Pract; 2008 Nov; 110(2):c93-100. PubMed ID: 18815449 [Abstract] [Full Text] [Related]
10. Serum NT-proBNP concentrations in the early phase do not predict the severity of systolic or diastolic left ventricular dysfunction among patients with ST-elevation acute myocardial infarction. Ben-Dor I, Haim M, Rechavia E, Murninkas D, Harell D, Porter A, Iakobishvili Z, Battler A, Hasdai D. Angiology; 2008 Nov; 57(6):686-93. PubMed ID: 17235108 [Abstract] [Full Text] [Related]
11. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function. Rothenburger M, Stypmann J, Bruch C, Wichter T, Hoppe M, Drees G, Berendes E, Huelsken G, Loeher A, Welp H, Röttger C, Schmid C, Scheld HH, Tjan TD. J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040 [Abstract] [Full Text] [Related]
12. Changes in B-type natriuretic peptides after surgical ventricular restoration. Sartipy U, Albåge A, Larsson PT, Insulander P, Lindblom D. Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144 [Abstract] [Full Text] [Related]
14. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study. Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S. Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244 [Abstract] [Full Text] [Related]
15. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD. Am J Cardiol; 2011 Nov 01; 108(9):1316-21. PubMed ID: 21871590 [Abstract] [Full Text] [Related]
16. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients. Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M. J Cardiovasc Med (Hagerstown); 2009 Mar 01; 10(3):238-44. PubMed ID: 19262210 [Abstract] [Full Text] [Related]
17. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M. Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312 [Abstract] [Full Text] [Related]
18. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Toblli JE, Lombraña A, Duarte P, Di Gennaro F. J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147 [Abstract] [Full Text] [Related]
19. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction. Ikeda N, Yasu T, Nishikimi T, Nakamura T, Kubo N, Kawakami M, Momomura S, Saito M. Regul Pept; 2007 Jun 07; 141(1-3):154-8. PubMed ID: 17292492 [Abstract] [Full Text] [Related]
20. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. Magga J, Sipola P, Vuolteenaho O, Risteli J, Jääskeläinen P, Peuhkurinen K, Kuusisto J. Am J Cardiol; 2008 Apr 15; 101(8):1185-90. PubMed ID: 18394456 [Abstract] [Full Text] [Related] Page: [Next] [New Search]